Peripheral blood leukocyte expression level of lncRNA steroid receptor RNA activator (SRA) and its association with polycystic ovary syndrome: A case control study

Gynecological Endocrinology

Volumn 31, Issue 5, 2015, Pages 363-368

  Liu, Zhenteng ^a,b   Hao, Cuifang ^b   Huang, Xin ^b   Zhang, Ning ^b   Bao, Hongchu ^b   Qu, Qinglan ^b  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b QINGDAO UNIVERSITY   (China)

Author keywords

BMI; LncRNA; Obesity; PCOS; SRA

Indexed keywords

LONG UNTRANSLATED RNA; CARRIER PROTEIN; STEROID RECEPTOR RNA ACTIVATOR, HUMAN;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; LEUKOCYTE; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEROID RECEPTOR RNA ACTIVATOR GENE; COMPLICATION; GENETICS; METABOLISM;

ADULT; CARRIER PROTEINS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEUKOCYTES; OBESITY; POLYCYSTIC OVARY SYNDROME; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, LONG NONCODING;

EID: 84931362726     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.999763     Document Type: Article

References (37)

1. Li R, Zhang Q, Yang D, et al. Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod 2013;28:2562-9.
2. Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2013;98: 4565-92.
3. Gambineri A, Pelusi C, Vicennati V, et al. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 2002;26:883-96.
4. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011;7:219-31.
5. Roberts TC, Morris KV, Weinberg MS. Perspectives on the mechanism of transcriptional regulation by long non-coding RNAs. Epigenetics 2014;9:13-20.
6. Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 2012;22:1775-89.
7. Li X, Wu Z, Fu X, Han W. Long noncoding RNAs: insights from biological features and functions to diseases. Med Res Rev 2013;33: 517-53.
8. Lanz RB, McKenna NJ, Onate SA, et al. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 1999;97:17-27.
9. Colley SM, Leedman PJ. Steroid receptor RNA activator-a nuclear receptor coregulator with multiple partners: insights and challenges. Biochimie 2011;93:1966-72.
10. Xu B, Koenig RJ. An RNA-binding domain in the thyroid hormone receptor enhances transcriptional activation. J Biol Chem 2004;279: 33051-6.
11. Zhao X, Patton JR, Davis SL, et al. Regulation of nuclear receptor activity by a pseudouridine synthase through posttranscriptional modification of steroid receptor RNA activator. Mol Cell 2004;15: 549-58.
12. Caretti G, Schiltz RL, Dilworth FJ, et al. The RNA helicases p68/ p72 and the noncoding RNA SRA are coregulators of MyoD and skeletal muscle differentiation. Dev Cell 2006;11:547-60.
13. Xu B, Yang WH, Gerin I, et al. Dax-1 and steroid receptor RNA activator (SRA) function as transcriptional coactivators for steroidogenic factor 1 in steroidogenesis. Mol Cell Biol 2009;29: 1719-34.
14. Emberley E, Huang GJ, Hamedani MK, et al. Identification of new human coding steroid receptor RNA activator isoforms. Biochem Biophys Res Commun 2003;301:509-15.
15. Kawashima H, Takano H, Sugita S, et al. A novel steroid receptor co-activator protein (SRAP) as an alternative form of steroid receptor RNA-activator gene: expression in prostate cancer cells and enhancement of androgen receptor activity. Biochem J 2003;369: 163-71.
16. Oleszczak B, Szablewski L, Pliszka M, et al. Transport of deoxy-Dglucose into lymphocytes of patients with polycystic ovary syndrome. Endocrine 2014;47:618-24.
17. Rotterdam EA-SPcwg Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-7.
18. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:45e-45.
19. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101-8.
20. Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet 2014;15:7-21.
21. Cooper C, Guo J, Yan Y, et al. Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides. Nucleic Acids Res 2009;37:4518-31.
22. Lanz RB, Chua SS, Barron N, et al. Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo. Mol Cell Biol 2003;23:7163-76.
23. Agoulnik IU, Weigel NL. Coactivator selective regulation of androgen receptor activity. Steroids 2009;74:669-74.
24. Liu S, Sheng L, Miao H, et al. SRA gene knockout protects against diet-induced obesity and improves glucose tolerance. J Biol Chem 2014;289:13000-9.
25. Liu S, Xu R, Gerin I, et al. SRA regulates adipogenesis by modulating p38/JNK phosphorylation and stimulating insulin receptor gene expression and downstream signaling. PLoS One 2014;9: e95416.
26. Xu B, Gerin I, Miao H, et al. Multiple roles for the non-coding RNA SRA in regulation of adipogenesis and insulin sensitivity. PLoS One 2010;5:e14199.
27. Jakimiuk AJ, Weitsman SR, Yen HW, et al. Estrogen receptor alpha and beta expression in theca and granulosa cells from women with polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87: 5532-8.
28. Lydon JP, DeMayo FJ, Funk CR, et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 1995;9:2266-78.
29. Zurvarra FM, Salvetti NR, Mason JI, et al. Disruption in the expression and immunolocalisation of steroid receptors and steroidogenic enzymes in letrozole-induced polycystic ovaries in rat. Reprod Fertil Dev 2009;21:827-39.
30. Leygue E, Dotzlaw H, Watson PH, Murphy LC. Expression of the steroid receptor RNA activator in human breast tumors. Cancer Res 1999;59:4190-3.
31. Lanz RB, Chua SS, Barron N, et al. Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo. Mol Cell Biol 2003;23:7163-76.
32. Zhao X, Patton JR, Davis SL, et al. Regulation of nuclear receptor activity by a pseudouridine synthase through posttranscriptional modification of steroid receptor RNA activator. Mol Cell 2004;15: 549-58.
33. Takayama K, Tsutsumi S, Katayama S, et al. Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells. Oncogene 2011;30:619-30.
34. Barber TM, McCarthy MI, Wass JA, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf) 2006;65: 137-45.
35. Kawashima H, Takano H, Sugita S, et al. A novel steroid receptor co-activator protein (SRAP) as an alternative form of steroid receptor RNA-activator gene: expression in prostate cancer cells and enhancement of androgen receptor activity. Biochem J 2003;369: 163-71.
36. Chooniedass-Kothari S, Emberley E, Hamedani MK, et al. The steroid receptor RNA activator is the first functional RNA encoding a protein. Febs Lett 2004;566:43-7.
37. Colley SM, Leedman PJ. Steroid receptor RNA activator-a nuclear receptor coregulator with multiple partners: Insights and challenges. Biochimie 2011;93:1966-72.